Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
70
AGYS Quote, Financials, Valuation and Earnings
Last price:
$119.58
Seasonality move
:
-0.25%
Day range:
$113.75 - $119.43
52-week range:
$63.71 - $142.64
Dividend yield:
0%
P/E ratio:
140.75x
P/S ratio:
11.97x
P/B ratio:
12.31x
Volume:
240.7K
Avg. volume:
254.2K
1-year change:
7.31%
Market cap:
$3.3B
Revenue:
$275.6M
EPS (TTM):
$0.83
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137.2M | $162.6M | $198.1M | $237.5M | $275.6M | |
| Revenue Growth (YoY) | -14.67% | 18.56% | 21.78% | 19.89% | 16.07% | |
| Cost of Revenues | $47.8M | $61.1M | $77.2M | $93.2M | $103.6M | |
| Gross Profit | $89.4M | $101.5M | $120.8M | $144.3M | $172M | |
| Gross Profit Margin | 65.15% | 62.43% | 61% | 60.75% | 62.4% | |
| R&D Expenses | $55.3M | $46.3M | $50.3M | $56.7M | $62.4M | |
| Selling, General & Admin | $47.5M | $42.5M | $53.4M | $64.7M | $74M | |
| Other Inc / (Exp) | -$538K | -$824K | $345K | -$180K | -$53K | |
| Operating Expenses | $110.1M | $94.2M | $107.6M | $128.5M | $148.6M | |
| Operating Income | -$20.8M | $7.3M | $13.2M | $15.8M | $23.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$21.2M | $6.5M | $15.8M | $20.7M | $25.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$208K | $33K | $1.2M | -$65.5M | $2.4M | |
| Net Income to Company | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Basic EPS (Cont. Ops) | -$1.01 | $0.19 | $0.52 | $3.31 | $0.84 | |
| Diluted EPS (Cont. Ops) | -$1.01 | $0.18 | $0.49 | $3.17 | $0.82 | |
| Weighted Average Basic Share | $23.5M | $24.4M | $24.7M | $25.7M | $27.5M | |
| Weighted Average Diluted Share | $23.5M | $25.5M | $25.9M | $26.8M | $28.3M | |
| EBITDA | -$16.4M | $10.4M | $19.4M | $26.1M | $35.2M | |
| EBIT | -$21.2M | $6.5M | $15.8M | $20.7M | $27.2M | |
| Revenue (Reported) | $137.2M | $162.6M | $198.1M | $237.5M | $275.6M | |
| Operating Income (Reported) | -$20.8M | $7.3M | $13.2M | $15.8M | $23.4M | |
| Operating Income (Adjusted) | -$21.2M | $6.5M | $15.8M | $20.7M | $27.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $36.3M | $46.6M | $52.9M | $62.2M | $74.3M | |
| Revenue Growth (YoY) | -8.38% | 28.13% | 13.62% | 17.63% | 19.37% | |
| Cost of Revenues | $12.9M | $18.9M | $20.7M | $23.9M | $29.2M | |
| Gross Profit | $23.5M | $27.7M | $32.2M | $38.3M | $45.1M | |
| Gross Profit Margin | 64.61% | 59.48% | 60.84% | 61.52% | 60.66% | |
| R&D Expenses | $26.4M | $12.3M | $13.7M | $14.3M | $16.5M | |
| Selling, General & Admin | $20.7M | $11.7M | $13.9M | $17.7M | $19M | |
| Other Inc / (Exp) | $2.6M | $787K | -$350K | -$165K | -$158K | |
| Operating Expenses | $50.9M | $26.7M | $28.5M | $34.8M | $39.6M | |
| Operating Income | -$27.4M | $956K | $3.7M | $3.5M | $5.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$24.8M | $1.8M | $4.3M | $4.8M | $5.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$519K | -$232K | $262K | $1.9M | $1.4M | |
| Net Income to Company | -$24.3M | $2M | $4.1M | $3M | $3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$24.3M | $2M | $4.1M | $3M | $3.9M | |
| Basic EPS (Cont. Ops) | -$1.05 | $0.06 | $0.15 | $0.11 | $0.14 | |
| Diluted EPS (Cont. Ops) | -$1.05 | $0.06 | $0.14 | $0.11 | $0.14 | |
| Weighted Average Basic Share | $23.6M | $24.5M | $24.8M | $26.9M | $27.7M | |
| Weighted Average Diluted Share | $23.6M | $26M | $26.4M | $28M | $28.3M | |
| EBITDA | -$23.7M | $2.9M | $7.2M | $6.1M | $8.3M | |
| EBIT | -$24.8M | $1.8M | $6.2M | $4.8M | $5.8M | |
| Revenue (Reported) | $36.3M | $46.6M | $52.9M | $62.2M | $74.3M | |
| Operating Income (Reported) | -$27.4M | $956K | $3.7M | $3.5M | $5.5M | |
| Operating Income (Adjusted) | -$24.8M | $1.8M | $6.2M | $4.8M | $5.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $137.2M | $162.6M | $198.1M | $237.5M | $275.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $47.8M | $61.1M | $77.2M | $93.2M | $103.6M | |
| Gross Profit | $89.4M | $101.5M | $120.8M | $144.3M | $172M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $55.3M | $46.3M | $50.3M | $56.7M | $62.4M | |
| Selling, General & Admin | $47.5M | $42.5M | $53.4M | $64.7M | $74M | |
| Other Inc / (Exp) | -$543K | -$17K | $346K | -$178K | -$57K | |
| Operating Expenses | $110.1M | $95M | $107.6M | $128.5M | $148.6M | |
| Operating Income | -$20.8M | $6.5M | $13.2M | $15.8M | $23.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$21.2M | $6.5M | $15.8M | $20.7M | $25.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$208K | $33K | $1.2M | -$65.5M | $2.4M | |
| Net Income to Company | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Basic EPS (Cont. Ops) | -$1.00 | $0.18 | $0.52 | $3.29 | $0.85 | |
| Diluted EPS (Cont. Ops) | -$1.01 | $0.18 | $0.49 | $3.16 | $0.83 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$16.4M | $10.4M | $20.3M | $25.2M | $33.8M | |
| EBIT | -$21.2M | $6.5M | $16.7M | $19.7M | $25.8M | |
| Revenue (Reported) | $137.2M | $162.6M | $198.1M | $237.5M | $275.6M | |
| Operating Income (Reported) | -$20.8M | $6.5M | $13.2M | $15.8M | $23.4M | |
| Operating Income (Adjusted) | -$21.2M | $6.5M | $16.7M | $19.7M | $25.8M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $162.6M | $198.1M | $237.5M | $275.6M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $61.1M | $77.2M | $93.2M | $103.6M | -- | |
| Gross Profit | $101.5M | $120.8M | $144.3M | $172M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $46.3M | $50.3M | $56.7M | $62.4M | -- | |
| Selling, General & Admin | $42.5M | $53.4M | $64.7M | $74M | -- | |
| Other Inc / (Exp) | -$17K | $346K | -$178K | -$57K | -- | |
| Operating Expenses | $95M | $107.6M | $128.5M | $148.6M | -- | |
| Operating Income | $6.5M | $13.2M | $15.8M | $23.4M | -- | |
| Net Interest Expenses | -- | -- | -- | $241K | -- | |
| EBT. Incl. Unusual Items | $6.5M | $15.8M | $20.7M | $25.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $33K | $1.2M | -$65.5M | $2.4M | -- | |
| Net Income to Company | $6.5M | $14.6M | $86.2M | $23.2M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.5M | $14.6M | $86.2M | $23.2M | -- | |
| Basic EPS (Cont. Ops) | $0.18 | $0.52 | $3.29 | $0.85 | -- | |
| Diluted EPS (Cont. Ops) | $0.18 | $0.49 | $3.16 | $0.83 | -- | |
| Weighted Average Basic Share | $97.4M | $98.8M | $102.7M | $110.1M | -- | |
| Weighted Average Diluted Share | $101.9M | $103.6M | $107.3M | $113M | -- | |
| EBITDA | $10.4M | $20.3M | $25.2M | $33.8M | -- | |
| EBIT | $6.5M | $16.7M | $19.7M | $25.8M | -- | |
| Revenue (Reported) | $162.6M | $198.1M | $237.5M | $275.6M | -- | |
| Operating Income (Reported) | $6.5M | $13.2M | $15.8M | $23.4M | -- | |
| Operating Income (Adjusted) | $6.5M | $16.7M | $19.7M | $25.8M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $25.7M | $25.2M | $22.4M | $29.4M | $31.5M | |
| Inventory | $1.2M | $6.9M | $9.8M | $4.6M | $5.2M | |
| Prepaid Expenses | -- | -- | -- | $7.3M | $8.1M | |
| Other Current Assets | $4.8M | $5.4M | $7.4M | $401K | $1.2M | |
| Total Current Assets | $133.3M | $136.2M | $154.7M | $188.9M | $123.5M | |
| Property Plant And Equipment | $21M | $16.2M | $27.3M | $36.3M | $33.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $19.6M | $32.8M | $32.6M | $32.8M | $130.6M | |
| Other Intangibles | $8.4M | $20.2M | $18.1M | $17M | $70.8M | |
| Other Long-Term Assets | $5.8M | $6.2M | $7.5M | $8.1M | $9M | |
| Total Assets | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Accounts Payable | $6.3M | $9.8M | $9.4M | $9.4M | $12.4M | |
| Accrued Expenses | $9.5M | $8.6M | $11.6M | $17.8M | $20.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5M | $5.1M | $3.3M | $4.3M | $5.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $61.2M | $71.5M | $78.5M | $89.4M | $111M | |
| Long-Term Debt | -- | -- | -- | -- | $24M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $74.5M | $81.4M | $98.3M | $114M | $168.5M | |
| Common Stock | $44.9M | $44.9M | $44.9M | $10M | $10M | |
| Other Common Equity Adj | $39K | -$56K | -$4M | -$4.2M | -$13.3M | |
| Common Equity | $79.9M | $97.3M | $109.3M | $236.5M | $265.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $115.3M | $132.8M | $144.8M | $236.5M | $265.9M | |
| Total Liabilities and Equity | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Cash and Short Terms | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Total Debt | -- | -- | -- | -- | $24M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $25.7M | $25.2M | $22.4M | $29.4M | $31.5M | |
| Inventory | $1.2M | $6.9M | $9.8M | $4.6M | $5.2M | |
| Prepaid Expenses | -- | -- | -- | $7.3M | $8.1M | |
| Other Current Assets | $4.8M | $5.4M | $7.4M | $401K | $1.2M | |
| Total Current Assets | $133.3M | $136.2M | $154.7M | $188.9M | $123.5M | |
| Property Plant And Equipment | $21M | $16.2M | $27.3M | $36.3M | $33.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $19.6M | $32.8M | $32.6M | $32.8M | $130.6M | |
| Other Intangibles | $8.4M | $20.2M | $18.1M | $17M | $70.8M | |
| Other Long-Term Assets | $5.8M | $6.2M | $7.5M | $8.1M | $9M | |
| Total Assets | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Accounts Payable | $6.3M | $9.8M | $9.4M | $9.4M | $12.4M | |
| Accrued Expenses | $9.5M | $8.6M | $11.6M | $17.8M | $20.8M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $5M | $5.1M | $3.3M | $4.3M | $5.7M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $61.2M | $71.5M | $78.5M | $89.4M | $111M | |
| Long-Term Debt | -- | -- | -- | -- | $24M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $74.5M | $81.4M | $98.3M | $114M | $168.5M | |
| Common Stock | $44.9M | $44.9M | $44.9M | $10M | $10M | |
| Other Common Equity Adj | $39K | -$56K | -$4M | -$4.2M | -$13.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $115.3M | $132.8M | $144.8M | $236.5M | $265.9M | |
| Total Liabilities and Equity | $189.9M | $214.2M | $243M | $350.4M | $434.4M | |
| Cash and Short Terms | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Total Debt | -- | -- | -- | -- | $24M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Depreciation & Amoritzation | $4.8M | $3.9M | $3.7M | $5.4M | $8M | |
| Stock-Based Compensation | $40.1M | $14.5M | $13M | $14.1M | $17.8M | |
| Change in Accounts Receivable | $10.1M | $3.2M | $1.9M | -$7M | -$2.8M | |
| Change in Inventories | $2.7M | -$5.8M | -$2.9M | $5.2M | -$556K | |
| Cash From Operations | $28.4M | $28.5M | $34.5M | $48.2M | $55.1M | |
| Capital Expenditures | $1.4M | $1.2M | $7.2M | $8.1M | $2.8M | |
| Cash Acquisitions | -- | -$24.5M | $395K | -- | -$145.8M | |
| Cash From Investing | -$1.4M | -$25.7M | -$6.9M | -$7.6M | -$148.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.1M | -$1.8M | -$1.8M | -$1.7M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | $49.6M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$26M | |
| Repurchase of Common Stock | -$7.5M | -$3M | -$9.3M | -$6.9M | -$2.7M | |
| Other Financing Activities | -$24K | -$19K | -$4K | -$2K | -- | |
| Cash From Financing | $25.3M | -$4.9M | -$11.1M | -$8.6M | $21.9M | |
| Beginning Cash (CF) | $46.7M | $99.2M | $97M | $112.8M | $144.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $52.3M | -$2.1M | $16.5M | $32M | -$71.5M | |
| Ending Cash (CF) | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Levered Free Cash Flow | $27M | $27.3M | $27.2M | $40.1M | $52.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$24.3M | $2M | $4.1M | $3M | $3.9M | |
| Depreciation & Amoritzation | $1.1M | $1.2M | $974K | $1.3M | $2.5M | |
| Stock-Based Compensation | $30.8M | $3.7M | $3.5M | $4.6M | $5.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $13.3M | $6.7M | $16.8M | $29.8M | $27.2M | |
| Capital Expenditures | $313K | $119K | $3.6M | $469K | $701K | |
| Cash Acquisitions | -- | -- | -- | -- | -$811K | |
| Cash From Investing | -$313K | -$24.6M | -$3.2M | $58K | -$1.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -$1K | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$14M | |
| Repurchase of Common Stock | -$6.4M | -$144K | -$6.3M | -$1.2M | $105K | |
| Other Financing Activities | -$6K | -$3K | -$1K | -- | -- | |
| Cash From Financing | -$6.4M | -$147K | -$6.3M | -$1.2M | -$13.3M | |
| Beginning Cash (CF) | $92.6M | $115.1M | $105.8M | $116.2M | $60.8M | |
| Foreign Exchange Rate Adjustment | $11K | -$66K | -$201K | -$15K | -$37K | |
| Additions / Reductions | $6.6M | -$18.1M | $7.2M | $28.7M | $12.3M | |
| Ending Cash (CF) | $99.2M | $97M | $112.8M | $144.9M | $73M | |
| Levered Free Cash Flow | $13M | $6.5M | $13.2M | $29.3M | $26.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$21M | $6.5M | $14.6M | $86.2M | $23.2M | |
| Depreciation & Amoritzation | $4.8M | $3.9M | $3.7M | $5.4M | $8M | |
| Stock-Based Compensation | $40.1M | $14.5M | $13M | $14.1M | $17.8M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $28.4M | $28.5M | $34.5M | $48.2M | $55.1M | |
| Capital Expenditures | $1.4M | $1.2M | $7.2M | $8.1M | $2.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -$145.8M | |
| Cash From Investing | -$1.4M | -$25.7M | -$6.9M | -$7.6M | -$148.6M | |
| Dividends Paid (Ex Special Dividend) | -$1.1M | -$1.8M | -$1.8M | -$1.7M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$7.5M | -$3M | -$9.3M | -$6.9M | -$2.7M | |
| Other Financing Activities | -$24K | -$19K | -$4K | -$2K | -- | |
| Cash From Financing | $25.3M | -$4.9M | -$11.1M | -$8.6M | $21.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $52.3M | -$2.1M | $16.5M | $32M | -$71.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $27M | $27.3M | $27.2M | $40.1M | $52.3M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.5M | $14.6M | $86.2M | $23.2M | -- | |
| Depreciation & Amoritzation | $3.9M | $3.7M | $5.4M | $8M | -- | |
| Stock-Based Compensation | $14.5M | $13M | $14.1M | $17.8M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $28.5M | $34.5M | $48.2M | $55.1M | -- | |
| Capital Expenditures | $1.2M | $7.2M | $8.1M | $2.8M | -- | |
| Cash Acquisitions | -- | -- | -- | -$145.8M | -- | |
| Cash From Investing | -$25.7M | -$6.9M | -$7.6M | -$148.6M | -- | |
| Dividends Paid (Ex Special Dividend) | -$1.8M | -$1.8M | -$1.7M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $49.6M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$26M | -- | |
| Repurchase of Common Stock | -$3M | -$9.3M | -$6.9M | -$2.7M | -- | |
| Other Financing Activities | -$19K | -$4K | -$2K | -- | -- | |
| Cash From Financing | -$4.9M | -$11.1M | -$8.6M | $21.9M | -- | |
| Beginning Cash (CF) | $424.6M | $393.9M | $443.5M | $404.7M | -- | |
| Foreign Exchange Rate Adjustment | -$104K | -$628K | $23K | -$340K | -- | |
| Additions / Reductions | -$2.1M | $16.5M | $32M | -$71.5M | -- | |
| Ending Cash (CF) | $422.4M | $409.8M | $475.6M | $332.8M | -- | |
| Levered Free Cash Flow | $27.3M | $27.2M | $40.1M | $52.3M | -- | |
Get AGYS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AGYS
Sector
P/E ratio
140.75x
23.84x
PEG ratio
0.04x
0.00x
P/B ratio
12.31x
2.31x
Price / LTM sales
11.97x
1.64x
Growth Metrics
AGYS
Sector
Revenue growth
19.37%
3.84%
Earnings growth
27.27%
10.8%
Revenue (5-year growth)
11.39%
6.27%
Earnings forecast
$0.36
$0.12
Profitability
AGYS
Sector
Profitability FY 2024
$172M
$77.3M
Return on invested capital
8.38%
0.05%
Return on assets
5.73%
-0.48%
Return on equity
9.12%
0.73%
Earnings Date
Last Earnings Date
May
19
Next Earnings Date
Jul
21
Estimated Next Earnings Date
Aug
18
Balance Sheet
AGYS
Sector
Total cash
$73M
$48.7M
Short term investments
--
$19.4M
Total assets
$434.4M
$223.8M
Long term debt
$24M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
